会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Methods for detecting lesions in dense breast tissue using LHRH antagonists
    • 使用LHRH拮抗剂检测致密乳腺组织病变的方法
    • US06540979B2
    • 2003-04-01
    • US09764626
    • 2001-01-18
    • Marc B. Garnick
    • Marc B. Garnick
    • A61B5055
    • A61K49/00
    • Improved methods for detecting lesions in dense breast tissue are disclosed. The methods of the invention generally feature administration to a subject of an LHRH antagonist in an amount and for a period of time sufficient to reduce the density of breast tissue prior to generating an image of the breast tissue, for example by mammography, to detect a lesion in the breast tissue. Packaged formulations for reducing breast density in a subject prior to generating an image of the subject's breast tissue, comprising an LHRH antagonist packaged with instructions for using the LHRH antagonist to reduce breast density in a subject prior to imaging the breast tissue, are also disclosed.
    • 公开了用于检测致密乳房组织中病变的改进方法。 本发明的方法通常特征在于在产生乳房组织的图像(例如通过乳房X线照相术)之前足以减少乳房组织的密度的量和一段时间的时间内向LHRH拮抗剂的受试者施用,以检测 乳腺组织病变。 还公开了用于在产生受试者的乳腺组织的图像之前减少受试者的乳房密度的包装制剂,其包含与在成像乳腺组织之前使用LHRH拮抗剂降低受试者的乳腺密度的说明书一起包装的LHRH拮抗剂。
    • 5. 发明授权
    • Methods for detecting lesions in dense breast tissue using LHRH antagonists
    • 使用LHRH拮抗剂检测致密乳腺组织病变的方法
    • US06737039B2
    • 2004-05-18
    • US10319140
    • 2002-12-12
    • Marc B. Garnick
    • Marc B. Garnick
    • A61B5055
    • A61K49/00
    • Improved methods for detecting lesions in dense breast tissue are disclosed. The methods of the invention generally feature administration to a subject of an LHRH antagonist in an amount and for a period of time sufficient to reduce the density of breast tissue prior to generating an image of the breast tissue, for example by mammography, to detect a lesion in the breast tissue. Packaged formulations for reducing breast density in a subject prior to generating an image of the subject's breast tissue, comprising an LHRH antagonist packaged with instructions for using the LHRH antagonist to reduce breast density in a subject prior to imaging the breast tissue, are also disclosed.
    • 公开了用于检测致密乳房组织中病变的改进方法。 本发明的方法通常特征在于在产生乳房组织的图像(例如通过乳房X线照相术)之前足以减少乳房组织的密度的量和一段时间的时间内向LHRH拮抗剂的受试者施用,以检测 乳腺组织病变。 还公开了用于在产生受试者的乳腺组织的图像之前减少受试者的乳房密度的包装制剂,其包含与在成像乳腺组织之前使用LHRH拮抗剂降低受试者的乳腺密度的说明书一起包装的LHRH拮抗剂。
    • 6. 发明授权
    • Methods for treating hot flashes and gynaecomastia
    • 治疗潮热和女性乳房发育的方法
    • US06703367B1
    • 2004-03-09
    • US09674132
    • 2001-02-16
    • Marc B. Garnick
    • Marc B. Garnick
    • A61K3809
    • C07K7/23A61K38/00Y10S514/80
    • Methods to inhibit hot flashes or gynaecomastia in a subject are provided. In the methods of the invention, an LHRH antagonist is administered to a subject in need of treatment for hot flashes or gynaecomastia such that hot flashes or gynaecomastia are inhibited in the subject. In a particularly preferred embodiment, the invention provides a method for inhibiting menopause-related hot flashes in which an LHRH antagonist is administered to a subject in need of treatment for menopause-related hot flashes such that the hot flashes are inhibited in the subject.
    • 提供了抑制受试者中的潮热或女性乳房发育的方法。 在本发明的方法中,将LHRH拮抗剂施用于需要治疗热潮红或女性乳房发育的受试者,使得受试者中的潮热或女性乳房发育被抑制。 在特别优选的实施方案中,本发明提供了一种抑制更年期相关热潮红的方法,其中将LHRH拮抗剂施用于需要治疗绝经期相关热潮红的受试者,使得受试者中的潮热被抑制。